上海市胸科医院与上海交通大学附属胸科医院一个机构两块牌子，位于中国上海市淮海西路241号。该院是一所主要诊治心胸疾病为主的三级甲等医院，1957年被中华人民共和国卫生部指定为全国心胸外科进修基地，1988年成为上海第二医科大学的教学医院，2004年成为上海红十字胸科医院，2005年成为上海交通大学附属胸科医院。

During the past decade, Shanghai Chest Hosptial conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Shanghai Chest Hosptial" are "Advanced Solid Tumor" (1 trials), "Liver Cancer" (1 trials), "Lung Cancer" (1 trials), "Lymphoma" (1 trials) and "Mesothelioma of Pleura" (1 trials). Many other conditions were trialed in "Shanghai Chest Hosptial" in a lesser frequency.

Most popular intervention types in "Shanghai Chest Hosptial" are "Biological" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Best Supportive Care (BSC)" (1 trials), "Placebo" (1 trials), "Saline" (1 trials), "Single low dose cyclophosphamide" (1 trials) and "T3011" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Chest Hosptial" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Shanghai Chest Hosptial". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Shanghai Chest Hosptial, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Chest Hosptial, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".